Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-13 4:01 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | Venrock Healthcare Capital Partners III L.P. | 2,214,142 5.4% | 2,214,142 (New Position) | View |
| 2023-02-27 4:05 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Venrock Healthcare Capital Partners III L.P. | 26,740,000 9.9% | 26,740,000 (New Position) | View |
| 2023-02-17 4:05 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Venrock Healthcare Capital Partners III L.P. | 1,352,285 9.99% | 1,352,285 (New Position) | View |
| 2023-02-14 4:30 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 4,230,621 9.99% | 2,025,353 (+91.84%) | View |
| 2023-02-14 4:07 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III L.P. | 2,208,812 6.4% | 136,803 (+6.60%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Venrock Healthcare Capital Partners III L.P. | 3,707,891 7.7% | 641,650 (+20.93%) | View |
| 2023-01-09 4:06 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III L.P. | 2,916,667 8.6% | 2,916,667 (New Position) | View |
| 2022-12-23 4:15 pm Purchase | 13G | CABALETTA BIO INC CABA | Venrock Healthcare Capital Partners III L.P. | 1,895,285 6.5% | 1,895,285 (New Position) | View |
| 2022-09-19 9:14 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III L.P. | 2,072,009 6.9% | 2,072,009 (New Position) | View |
| 2022-08-26 7:24 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Venrock Healthcare Capital Partners III L.P. | 3,066,241 8.2% | 3,066,241 (New Position) | View |
| 2022-02-14 4:19 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 2,205,268 9.99% | 262,213 (+13.49%) | View |
| 2021-10-14 4:05 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 1,943,055 9.99% | 1,943,055 (New Position) | View |
| 2021-02-16 4:11 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | Venrock Healthcare Capital Partners III L.P. | 4,040,000 4% | 1,250,000 (+44.80%) | View |
| 2021-02-16 4:08 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Venrock Healthcare Capital Partners III L.P. | 917,860 3.7% | -825,528 (-47.35%) | View |
| 2020-11-04 4:54 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | Venrock Healthcare Capital Partners III L.P. | 1,714,286 5.7% | 1,714,286 (New Position) | View |
| 2020-11-04 4:52 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Venrock Healthcare Capital Partners III L.P. | 1,743,388 7% | 1,743,388 (New Position) | View |
| 2020-01-21 4:52 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | Venrock Healthcare Capital Partners III L.P. | 2,790,000 9.95% | 2,790,000 (New Position) | View |